Provided by Tiger Trade Technology Pte. Ltd.

Plus Therapeutics, Inc.

0.2300
-0.0129-5.31%
Post-market: 0.2270-0.0030-1.30%19:57 EDT
Volume:3.62M
Turnover:832.57K
Market Cap:39.46M
PE:-0.79
High:0.2430
Open:0.2430
Low:0.2250
Close:0.2429
52wk High:1.36
52wk Low:0.1634
Shares:171.55M
Float Shares:170.90M
Volume Ratio:1.21
T/O Rate:2.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2900
EPS(LYR):-1.9544
ROE:-522.50%
ROA:-83.29%
PB:9.87
PE(LYR):-0.12

Loading ...

Plus Therapeutics appoints Ron Andrews to board of directors; Andrews brings 35 years of diagnostics experience

Reuters
·
Mar 26

Press Release: Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors

Dow Jones
·
Mar 26

Plus Therapeutics to present CNSide analysis showing 40% leptomeningeal metastases cost reduction at ISPOR 2026

Reuters
·
Mar 19

Lake Street Sticks to Their Buy Rating for Plus Therapeutics (PSTV)

TIPRANKS
·
Feb 26

Plus announces new Category III CPT code for CED used with Reyobiq

TIPRANKS
·
Feb 25

Plus Therapeutics Inc: Are on Track to Complete Enrollment in Phase 2 Recurrent Glioblastoma Trial in 2026

THOMSON REUTERS
·
Feb 25

Plus Therapeutics Announces New Category Iii Cpt Code for Convection-Enhanced Delivery Used With Reyobiq™

THOMSON REUTERS
·
Feb 25

Plus Therapeutics Inc - New Cpt Code Effective January 1, 2027

THOMSON REUTERS
·
Feb 25

Plus Therapeutics Announces New Category III CPT Code for REYOBIQ Convection-Enhanced Delivery

Reuters
·
Feb 25

Plus Therapeutics Approves 2025 Executive Compensation and Bonuses

Reuters
·
Feb 14

Plus Therapeutics (PSTV) Gets a Buy from Lake Street

TIPRANKS
·
Feb 05

Plus Therapeutics initiated with a Buy at Lake Street

TIPRANKS
·
Feb 03

Maxim Group Sticks to Their Buy Rating for Plus Therapeutics (PSTV)

TIPRANKS
·
Jan 23

Plus Therapeutics announces anticipated milestones for FY26

TIPRANKS
·
Jan 22

Plus Therapeutics Inc - Reyobiq Phase 2 Trial Data Expected in Q3 2026

THOMSON REUTERS
·
Jan 22

BRIEF-Plus Therapeutics To Provide Business Update On Thursday

Reuters
·
Jan 22

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET

GlobeNewswire
·
Jan 22

Benzinga Bulls And Bears: TSMC, Rocket Lab, J.B. Hunt — And Space Stocks Soar

Benzinga_recent_news
·
Jan 17

BRIEF-Plus Therapeutics Inc - On Jan 13, Co Enters Underwriting Agreement With Lake Street Capital Markets, Llc - SEC Filing

Reuters
·
Jan 17

Plus Therapeutics Inc - to Issue 39,473,684 Shares and Warrants at $0.38 Each - SEC Filing

THOMSON REUTERS
·
Jan 17